在肝癌治疗中使用 Cisplatin
Sae Hamaya1, Kyoko Oura1, Asahiro Morishita1
1Department of Gastroenterology and Neurology, Kagawa University Faculty of Medicine, Kita-gun 761-0793, Japan.
International journal of molecular sciences
|July 14, 2023
概括
西斯是晚期肝癌 (HCC) 的关键药物,但耐药性限制了其使用. 了解西斯普拉丁耐药机制对于开发肝细胞癌新疗法至关重要.
科学领域:
- 在瘤学瘤学.
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 肝细胞癌 (HCC) 是最常见的原发性肝癌,经常在晚期,无法切除的阶段被诊断出来.
- 目前的治疗方法,如跨动脉化学栓塞 (TACE) 和肝动脉输液化疗 (HAIC),仅限于肝脏内的病变.
- 系统疗法已经显示出有限的疗效,突出需要有效的治疗策略的先进的HCC.
研究的目的:
- 审查西斯在治疗肝胆癌症中的作用机制和耐药性.
- 专注于西斯在肝细胞癌 (HCC) 管理中的作用.
- 总结西斯在主要肝胆癌症中的应用.
主要方法:
- 文献综述总结了西斯的作用和抵抗机制.
- 分析西斯在治疗主要肝胆道癌症中的使用情况,重点是HCC.
- 讨论治疗策略的思普拉丁耐火性HCC.讨论.
主要成果:
- 西斯普拉丁用于通过透肝动脉给药局部治疗不可切除的晚期HCC.
- 对西斯的耐药性是一个重大挑战,需要采取替代治疗方法.
- 了解耐药机制是开发后续具有不同作用机制的全身疗法的关键.
结论:
- 西斯是治疗肝胆道癌症的重要药物,包括HCC.
- 解决西斯普拉丁耐药性对于改善晚期HCC治疗结果至关重要.
- 对于对西斯普拉丁耐药病例,需要对新型治疗策略进行进一步的研究.
更多相关视频
05:11Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
Published on: May 10, 2024
1.1K
07:47Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance
Published on: December 13, 2015
9.1K
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
